AI assistant
Sending…
Cardlytics, Inc. — Director's Dealing 2019
Aug 13, 2019
33956_dirs_2019-08-13_2241e5e0-ef89-4d36-9b21-e7d674c97adf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2019-08-12
Reporting Person: Weisman Tony (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-08-12 | Common Stock | M | 25000 | $9.08 | Acquired | 33484 | Direct |
| 2019-08-12 | Common Stock | S | 33484 | $31.36 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-08-12 | Stock Option (Right to Buy) | $9.08 | M | 25000 | Disposed | 2024-04-30 | Common Stock (25000) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.10 to $31.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: Fully vested.
More from Cardlytics, Inc.
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Annual Report
2026
Mar 4
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 19
Regulatory Filings
2026
Jan 26